{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:19:12Z","timestamp":1777054752458,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.neuroscience.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T21:27:51Z","timestamp":1641936471000},"page":"53-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High Level Forebrain Expression of Active Tau Kinase p38\u03b3 Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer\u2019s Mice"],"prefix":"10.1016","volume":"484","author":[{"given":"Prita R.","family":"Asih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristie","family":"Stefanoska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Prikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Ittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2022.01.005_b0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570586","article-title":"Functions of p38 MAP kinases in the central nervous system","volume":"13","author":"Asih","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00702-011-0626-5","article-title":"Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice","volume":"118","author":"Attems","year":"2011","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0020","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1523\/JNEUROSCI.22-13-05719.2002","article-title":"Transgenic calmodulin-dependent protein kinase II activation: dose-dependent effects on synaptic plasticity, learning, and memory","volume":"22","author":"Bejar","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fnins.2017.00672","article-title":"Loss of neuroprotective factors in neurodegenerative dementias: the end or the starting point?","volume":"11","author":"Benussi","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0030","doi-asserted-by":"crossref","first-page":"e0139914","DOI":"10.1371\/journal.pone.0139914","article-title":"Klotho protects dopaminergic neuron oxidant-induced degeneration by modulating ASK1 and p38 MAPK signaling pathways","volume":"10","author":"Brobey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0040","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/nprot.2006.450","article-title":"Stereotaxic gene delivery in the rodent brain","volume":"1","author":"Cetin","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb8255","article-title":"Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer's disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0055","first-page":"e2609","article-title":"Measuring motor coordination in mice","author":"Deacon","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0065","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1038\/mtna.2016.23","article-title":"Flexible, AAV-equipped genetic modules for inducible control of gene expression in mammalian brain","volume":"5","author":"Dogbevia","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/hum.2018.234","article-title":"Five years of successful inducible transgene expression following locoregional adeno-associated virus delivery in nonhuman primates with no detectable immunity","volume":"30","author":"Guilbaud","year":"2019","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnana.2019.00093","article-title":"Adeno-associated virus technologies and methods for targeted neuronal manipulation","volume":"13","author":"Haery","year":"2019","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0080","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/npp.2015.47","article-title":"Septal glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior","volume":"40","author":"Harasta","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fnins.2020.00286","article-title":"Role of alterations in protein kinase p38gamma in the pathogenesis of the synaptic pathology in dementia with lewy bodies and alpha-synuclein transgenic models","volume":"14","author":"Iba","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0090","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1006\/anbe.1996.0320","article-title":"Free food or earned food? A review and fuzzy model of contrafreeloading","volume":"53","author":"Inglis","year":"1997","journal-title":"Anim Behav"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-020-02191-1","article-title":"Reduction of advanced tau-mediated memory deficits by the MAP kinase p38gamma","volume":"140","author":"Ittner","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jnc.12821","article-title":"Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice","volume":"132","author":"Ittner","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0105","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer's mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer's disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0115","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00125-014-3230-z","article-title":"The nucleotide exchange factor SIL1 is required for glucose-stimulated insulin secretion from mouse pancreatic beta cells in vivo","volume":"57","author":"Ittner","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-4328(01)00443-0","article-title":"Association between experience of aggression and anxiety in male mice","volume":"133","author":"Kudryavtseva","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.gt.3301905","article-title":"Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area","volume":"10","author":"K\u00fcgler","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0135","doi-asserted-by":"crossref","first-page":"a021808","DOI":"10.1101\/cshperspect.a021808","article-title":"Place cells, grid cells, and memory","volume":"7","author":"Moser","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0140","doi-asserted-by":"crossref","first-page":"111623","DOI":"10.1016\/j.biopha.2021.111623","article-title":"Advances in developing therapeutic strategies for Alzheimer's disease","volume":"139","author":"Nguyen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","article-title":"Gene therapy in Alzheimer's disease - potential for disease modification","volume":"14","author":"Nilsson","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0150","doi-asserted-by":"crossref","first-page":"e1002440","DOI":"10.1371\/journal.pbio.1002440","article-title":"Kif13b regulates PNS and CNS myelination through the Dlg1 scaffold","volume":"14","author":"Noseda","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0165","doi-asserted-by":"crossref","first-page":"e0191794","DOI":"10.1371\/journal.pone.0191794","article-title":"Enhanced susceptibility to stress and seizures in GAD65 deficient mice","volume":"13","author":"Qi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2013.02.013","article-title":"Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes","volume":"245","author":"Reinecke","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj20031628","article-title":"Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90\/PSD-95 by activation of SAPK3\/p38gamma and ERK1\/ERK2","volume":"380","author":"Sabio","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.abi6401","article-title":"Treatments for Alzheimer's disease emerge","volume":"373","author":"Selkoe","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0195","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41598-018-24657-9","article-title":"Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP(NL-F\/NL-F) knock-in mice","volume":"8","author":"Shah","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0269881107073199","article-title":"The Open Field Test: reinventing the wheel","volume":"21","author":"Stanford","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0205","doi-asserted-by":"crossref","first-page":"14296","DOI":"10.1038\/s41598-018-32592-y","article-title":"Neuronal MAP kinase p38alpha inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour","volume":"8","author":"Stefanoska","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0210","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/REVNEURO.1999.10.1.15","article-title":"Transgenic animals in Alzheimer's disease research","volume":"10","author":"Sturchler-Pierrat","year":"1999","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0220","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","article-title":"MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition","volume":"33","author":"Taylor","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0225","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0230","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0235","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.0000109697.68832.5D","article-title":"Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors","volume":"109","author":"White","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0245","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1523\/JNEUROSCI.0541-05.2005","article-title":"Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase","volume":"25","author":"Wittmack","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0250","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1016\/j.neuroscience.2022.01.005_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.618171","article-title":"Gene therapy for neurodegenerative disease: clinical potential and directions","volume":"14","author":"Zhu","year":"2021","journal-title":"Front Mol Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:10:13Z","timestamp":1759680613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S0306452222000124"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.01.005","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Level Forebrain Expression of Active Tau Kinase p38\u03b3 Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer\u2019s Mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}